Atherosclerosis

Article	Citations
Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease	133
Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes	109
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study	100
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk	97
Common perinatal characteristics and adverse obstetric complications leading to overweight in adolescence: Assessment of independent and shared maternal-offspring pathways	92
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients	91
Lipid profile assessment as a factor of diabetic nephropathy progression	83
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium	79
Do triglycerides have an influence on endothelial function detected by Laser Doppler flowmetry?	79
Influence of low glycemic index diet on inflammatory state and lipid parameters in patients with atherosclerotic coronary artery disease	71
Age- and gender-specific lipid and lipoprotein levels and percentiles from the Thai National Health Examination Survey (NHES-VI) in Thailand	70
The reliability of coronary artery calcium score in symptomatic patients: Questioning the “power of zero”	68
Aging accelerates atherosclerosis development in C57BL/6 mice upon PCSK9 overexpression	68
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice	68
Genome-wide association study on HDL-mediated cholesterol efflux capacity	65
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?	65
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease	63
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	62
ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	60
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	59
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN	55
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]	54
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	53
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	53
TREM2 macrophages in adipose tissue and cardiovascular risk	49

IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	49
Illuminating the full spectrum of APOE variation	49
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	49
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	49
Editorial board	48
Gene set analysis of transcriptomics data identifies new biological processes associated with early markers of atherosclerosis but not with those of osteoporosis: Atherosclerosis-osteoporosis co/multi	48
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies	47
Bioactive lipids and lipoprotein lipase in epicardial adipose tissue from patients with coronary artery disease: Unfolding a missing link	45
An upregulation of scube 2 expression in type 2 diabetes mellitus with dyslipidemia	44
Associations of the fatty acids with the concentration of antioxidant enzymes in the blood in men with coronary heart disease	42
Reversing the functional- and regenerative capacity of senescent endothelial cells by pharmacological reprogramming	42
Tetrahydroxystilbene glycoside attenuates endothelial dysfunction and obesity-associated hypertension in obese rats: The role of omentin-1	41
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia	40
IL-21R blockade reduces atherosclerosis development	40
Circular decoys sponge miR-21 and miR-146a in senescent vascular cells	39
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study	37
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?	37
The real experience of reaching an extremely low LDL-C level in high risk patients	36
Vulnerable atheromatous plaque stabilization using extracorporeal shock wave- mediated sonoporation therapy- assisted HDL and atorvastatin combination therapy	36
Effect of B-mode ultrasound- guided extracorporeal low- level focused sonotherapy on early stage atherosclerosis regression using color doppler ultrasonography and histopathology	35
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis	35
The impact of cholesterol lowering drugs on metabolism and epigenetics	35
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy	35
Atherosclerosis in Brazil: An ecological study	33
Statin therapy and lipoprotein(a) levels: A systematic review and meta-analysis	32
Quality of life in older patients with obesity and chronic kidney disease	32
Collaboration of clinic and Biobank as an effective model for dyslipidemia research	32
Global Familial Hypercholesterolaemia Studies Collaboration (FHSC)	31
Genetic expression and immunofluorescence mapping of NaV1 highlight potential therapeutic targets in anti-inflammatory treatment of aortic valves stenosis	31
Influence of mineral bone disease biomarkers in carotid modeling as a marker of early atherosclerosis in dialysis patients	31
Management of significantly elevated lipoprotein(a) in patients without established ASCVD	30
Coronary computed tomography angiography-derived endothelial shear stress in myocardial bridging	30
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome	30
Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality	30
Assessment of the improvement in perfusion after endovascular intervention by hyperspectral imaging	30
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography	30
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity	30
The effect of MMP 9, TIMP-1 on the dynamics of cardiac fibrosis in patients with and without coronary artery disease 2 years after renal denervation	29
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial	29
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”	29
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue	29
Residual risk in coronary artery disease: Insights from an observational study	29
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification	29
Machine-learning-based models to predict atherogenic index of plasma range using oculomics and clinic variables in KNHANES for assessing the risk of cardiovascular disease	28
Sex differences in the treatment of familial hypercholesterolemia: A systematic review and meta-analysis	28
miR-148a-3p: A novel therapeutic candidate modulating angiogenesis and senescence for enhanced myocardial infarction recovery – experimental insights and targets explored	28
Circulating monocyte phenotype: A novel biomarker of atherosclerosis	28
Rare variants in U2-spliceosome genes are involved in autosomal dominant hypercholesterolemia	28
Statin treatment reduces long-term risk of revision surgery following total hip arthroplasty in osteoarthritis patients: A registry-based study	28
Dissecting sexual dimorphism in aortic valve stenosis by proteomics	28

Vascular structural changes in diabetes mellitus patients with chronic kidney disease	27
The comparative analyses of combined medicine alpha-lipoic acid and zinc with statins in the treatment of dyslipidemia in patients with atherosclerosis	27
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain	27
Comorbidities, frailty, and prognosis in elderly patients with atrial fibrillation and ischemic heart disease: Insights from a tertiary hospital cohort study	27
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage	27
Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention	27
Risk factors for progressive cardiorenal syndrome in patients with chronic kidney disease: The CRIC study	27
Rabies vaccine induced microangiopathy	26
Illness perception in patients with familial hypercholesterolemia	26
Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation	25
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis	25
Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study	24
Coronary artery calcium: The canary in the coal mine	24
The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia	24
Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport	24
Editorial Board	24
Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice	24
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus	24
Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction	24
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia	24
Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence	23
Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?	23
Bone mineral density and long-term progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis	23
Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study	23
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A	23
Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk	22
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia	22
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis	21
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling	21
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation	21
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT	21
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis	21
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial	21
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue	20
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis	20
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow	20
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus	20
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n	20
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis	20
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement	20
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease	19
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol	19
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials	19
Bivariate relation of vascular health and blood pressure progression during childhood	19
Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack	19
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity	19
Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging	19
Isolation and culture of murine aortic cells and RNA isolation of aortic intima and media: Rapid and optimized approaches for atherosclerosis research	19
Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study	19
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence	19
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease	19
The value of a negative study	19
Sociodemographic determinants of change in cardiovascular health in middle adulthood in a bi-racial cohort	19
Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation	19
Effect of biological sex on human circulating lipidome: An overview of the literature	18
Repeated measurement of lipoprotein(a): technical versus biological variability	18
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target	18
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes	18
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells	18
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)	18
Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey	17
Prevalence and prognostic impact of lipid goal attainment and patient adherence to lowering lipid treatment: Data from community Italian setting	17
ESTABLISHMENT OF ELISA SYSTEM FOR MODIFIED LDLADIPONECTIN COMPLEX	17
GENETIC AND BIOCHEMICAL ANALYSIS OF FOUR JAPANESE SEVERE HYPERTRIGLYCERIDEMIA	17
UCSCS IN TREATMENT OF T1DM AND T2DM; A META-ANALYSIS	17
ACCURACY OF TROPONIN VALUE IN ELDERLY WITH ACUTE CORONARY SYNDROME	17
METABOLOMIC ANALYSIS OF KAZAKH PATIENTS WITH METABOLIC SYNDROME BY GC/MS	17
COMPUTATIONAL IDENTIFICATION OF SMALL MOLECULES FOR MODULATING ATHEROSCLEROSIS AND NAFLD	17
LAUNCHOF THE FIRSTHOFH AWARENESS DAY: ADDRESSING UNMET NEEDS	17
Statin intolerance: What are we overlooking?	17
Polymorphic assessment of proprotein convertase subtilisin/kexin type 9 (PCSK9) variant rs11591147 in coronary artery disease subjects from Pakistan	17
Galectin-9: A novel promoter of atherosclerosis progression	17
FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE	17
CARDIO-PROTECTIVE ROLE OF ROSMARINIC ACID ON ISOPRENALINE INDUCED CARDIAC DYSFUNCTION	17
Orbital ischemia syndrome in a patient with carotid artery dissection - Case report	16
The use of seaweed-derived phytosterols to defeat Alzheimer's Disease	16
Protective role for body fat mass in atherogenesis among low cardiovascular risk patients	16
Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease	16
Protective effect of niclosamide on calcification of aortic valve interstitial cells and its underlying molecular mechanism	16
Nutritional approach in paediatric patients with familial hypercholesterolaemia	16

Professor Jeremiah Stamler (1919–2022), “Father of Preventive Cardiology”	16
Outcome of severe hypertriglyceridemia in hospital practice. A single centre experience from Singapore	16
Optimization and validation of lipoprotein(a) KIV2 isoform measurement in patients with familial hypercholesterolemia	16
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer	15
Epicardial adipose tissue and metabolic markers in dominican type 2 diabetics with preserved cardiac function	15
Evidence of proatherogenic inflammation in vascular endothelium of caviae porcellous infected with helicobacter pylori and exposed to high fat diet	15
The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes	15
Assessment of atherosclerotic lesions of the carotid arteries depending on the smoking index in patients with coronary artery disease	15
Cardiopulmonary exercise test alterations in young smokers with obesity	15
Increased values in total cholesterol and LDL cholesterol in “prediabetic” middle-aged and elderly adults with A1C between 5.7 and 6.4%	15
Double trouble: Pathogenic LDLR and SCARB1 variants in the same family	15
Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study	15
Mature natural killer type 2 cells and experimental atherosclerosis	15
P-selectin as a modulator of fibrin clot properties in patients treated with high-dose statins	15
Polygenic risk for future coronary artery disease events in familial hypercholesterolemia	15
Small LDL subfractions are associated with coronary atherosclerosis	15
Plasma concentrations of apolipoproteins and incident cardiovascular diseases in patients with type 2 diabetes	15
Vascular wall damage in atherosclerotic cardiovascular disease; Positive effect of extracellular vesicle-based nanotherapeutics on endothelial dysfunction and its key molecular players	15
Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis	15
High lipoprotein(A) increases risk of peripheral arterial disease, abdominal aortic aneurysms, and major adverse limb events	15
Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia	15
Treatment of vulnerable plaque using combined high-density lipoprotein and pentostatin- loaded microbubbles- mediated shock wave sonoporation therapy: Evaluation with positron emission tomography imag	14
In patients with cardiovascular disease and heart failure dental state (tooth loss) may exacerbate inflammatory syndrome	14
Region-specific lipid markers of human carotid atherosclerosis plaque outcome detected by matrix-assisted laser desorption/ionization mass spectrometry imaging	14
An innovative berberine formulation is able to improve bbr bioavailability and the lipid and glycemic profile in HFD-fed mice	14
Post-prandial analysis of fluctuations in the platelet count and platelet activity in patients with the familial chylomicronemia syndrome	14
Protein alterations in VSMCS reveal a defective repairment capacity in thoracic aortic aneurysm associated to BAV	14
VEGF-A levels and G634c gene polymorphism as a predictor of adverse outcomes in patients with STEMI	14
Arterial stiffness and glycometabolic control in older patients with type 2 diabetes	14
Editorial board	14
Investigation of the antioxidant and anti-inflammatory potency of Echinacea angustifolia extract	14
Heteroplasmy of atherosclerosis-associated mitochondrial DNA mutations and its effects on respiration and viability of cybrids	14
Chronic kidney disease induced atherosclerosis: The regulatory role of mIR-26b	14
Editorial Board	14
High and low levels of serum Sirtuin6 in patients with acute ischemic stroke	13
Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study	13
Positivity of statin-associated muscle symptoms – Clinical index in a hypertensive population candidated to lipid-lowering therapy but not taking statins	13
Granzyme B+ CD4+ T cells associate with an unstable plaque phenotype in advanced human atherosclerosis	13
New method of calculating low density lipoprotein cholesterol using Korea National Health and Nutrition Examination Survey (KNHANES) and its validation	13
Identification of circular RNA hsa_circ_0034621 as a novel biomarker for carotid atherosclerosis and the potential function as a regulator of NLRP3 inflammasome	13
Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH)	13
Ensemble machine learning for screening cardiovascular diseases in electronic health records	13
The patient will see you now: Patient preferences for lipid clinic reviews in a COVID era	13
Myeloid cannabinoid receptor CB1 deficiency limits macrophage proliferation and atherosclerosis in a sex-specific manner	13
Frequency of variants causing familial hypercholesterolaemia (FH) and impact on LDL-C concentration in individuals of South Asian and African ancestry in the UK Biobank	13
Dietary pattern of elderly people living in the rural area of Mortugaba (BA), Brazil	13
The condition of the main arteries in patients with chronic heart failure and diabetes mellitus	13
Reply to: “Longitudinal studies assessing retinal vascular characteristics in childhood and adolescence must account for ocular growth”	13
Non-esterified fatty acids and risk of peripheral artery disease in older adults: The cardiovascular health study	13
From fatty streaks to culprit lesions, the impact of PCSK9 on human atherosclerotic lesions through smooth muscle cells functions	13
LPA genotypes and haplotypes influence lipoprotein(a) levels but not arterial wall properties, in stable post-coronary event patients with very high lipoprotein(a) levels	13
The importance of cascade screening of familial hypercholesterolemia in routine clinical practice	13
Polymorphism of DNA repair genes (APEX1 T444G RS1130409) in obese gout patients in the male population of the trans-baikal territory in Russia	13
Association of parental obesity and body mass index in children of patients with early ischemic heart disease	13
Pediatric reference values for non-fasting lipids in French-Canadian children	13
Impact of ultrasound reverberation in calcified coronary arteries: Intravascular ultrasound study	13
Lipoprotein(a) and cardiovascular disease: Make use of the knowledge we have	13
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages	13
A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis	12
Clinical profile of familial hypercholesterolemia phenotype in adults attended in primary care in a large healthcare area	12
Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with 18F–NaF PET-CT	12
Long-term prognostic implications of hemodynamic and plaque assessment using coronary CT angiography	12
Genetic variation in ADAMTS13 are related to vWF levels, atrial fibrillation and cerebral ischemic events	12
Association between inflammatory markers levels, inflammatory intake of diet and adherence to the mediterranean diet	12
The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report	12
Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data	12
A novel homozygous variant in GPIHBP1 and familial chylomicronemia syndrome in latin America	12
Joint associations of peripheral artery disease and accelerometry-based physical activity with mortality: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)	12
Diet quality, front-of-pack labeling, and lipoprotein particle profiles	12
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals – an observational cross-sectional study	12
Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry	12
Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study	12
Compliance of heterozygous familial hypercholesterolemia patients: 5-years follow-up of the Russian familial hypercholesterolemia registry	12
Inflammation in COVID-19 is linked to pulmonary embolism and/or vascular tree-in-bud in hospitalized patients. The university hospital of Ioannina COVID-19 Registry, NCT05534074	12
Atherogenic lipidomics profile in healthy individuals with low cardiorespiratory fitness: The HUNT3 fitness study	12
Associations of alcohol intake with subclinical carotid atherosclerosis in 22,000 Chinese adults	12
Pigment epithelium-derived factor prevents endothelial dysfunction in early stage of hyperlipidemia by regulating endothelial fatty acid transport	12
A historical view of estrogen effect on arterial endothelial healing: From animal models to medical implication	12
Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35–75 years: Results from China PEACE Million Persons Project	12
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction	12
The polycomb repressive complex 2 (PRC2) in macrophages and atherosclerosis	11
Empagliflozin prevents human aortic smooth muscle cells damage induced by cholesterol	11
Predictors of functional and morphological arterial wall properties in patients with increased lipoprotein (a) before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors	11
Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity	11
Caveolin-1-mediated LDL transcytosis across endothelial cells in atherosclerosis	11
Impact of circulatory microRNA-126 &122 in severity of coronary artery disease correlation with small dense LDL: A case control study	11
Analysis of total cholesterol and its association with blood pressure, age and northern experience in men 25-54 years working on rotational shifts in the north	11
LIPC-E97G gain-of-function variant protects from dyslipidemia and atherosclerosis in mice independently of the LDL receptor	11
Infectious agent as a trigger mechanism of atherosclerosis and сerebrovascular diseases	11
Genetic testing increases the likelihood of a diagnosis of familial hypercholesterolaemia among people referred to lipid clinics: Danish national study	11
The interplay between lipoprotein(a) and inflammatory markers in atherosclerotic cardiovascular disease (ASCVD): A focus on neutrophil-to-lymphocyte ratio (NLR)	11
Lipoprotein(a) is a predictor of atherogenesis in patients with COPD	11
Management of hypercolesterolemic subjects at high cardiovascular risk with PCSK9 inhibitors: A “real life” experience in a lipid clinic in sicily	11
Lysosomal acid lipase (LAL) deficiency alters immune cells distribution in mice and humans	11
Gender disparities among contemporary patients with acute coronary syndrome: Data from CALLINICUS-hellas registry	11